Q2 2024 Syros Pharmaceuticals Inc Earnings Call Transcript

Author's Avatar
Jul 31, 2024

Jul 31, 2024 / 12:30PM GMT
Operator

Good morning, and welcome to Syros Pharmaceuticals Second Quarter 2024 financial results conference call. At this time, all participants are in listen only mode. This call is being webcast live on the Investors and Media section of Syros website at www.syros.com. Please be advised that today's call is being recorded. At this time, I would like to turn the call over to Karen Hunady, Director of Investor Relations and Corporate Communications at Syros.

Please go ahead.

Karen Hunady - Syros Pharmaceuticals Inc - Director of Corporate Communications & Investor Relations

Thank you

This morning, we issued a press release announcing our second quarter 2024 financial results. The full release is available on in the (technical difficulty) section of Syros' website at www.syros.com. We will begin the call with prepared remarks by Conley Chee, our Chief Executive Officer; Dr. David Roth, our Chief Medical Officer; and Jason Haas

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot